Boston Scientific

YTD

ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.

CEO

Michael F. Mahoney

CEOMichael F. Mahoney

Employees

53,000

Employees53,000

Headquarters

Marlborough, Massachusetts

HeadquartersMarlborough, Massachusetts

Founded

1979

Founded1979

Employees

53,000

Employees53,000

BSX Key Statistics

Market cap

135.83B

Market cap135.83B

Price-Earnings ratio

49.14

Price-Earnings ratio49.14

Dividend yield

—

Dividend yield—

Average volume

14.16M

Average volume14.16M

High today

$93.13

High today$93.13

Low today

$90.83

Low today$90.83

Open price

$91.61

Open price$91.61

Volume

20.36M

Volume20.36M

52 Week high

$109.50

52 Week high$109.50

52 Week low

$85.98

52 Week low$85.98

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $91.74. The company's market cap stands at 135.83B, with a P/E ratio of 49.14.

On 2026-02-03, Boston Scientific(BSX) stock moved within a range of $90.83 to $93.13. With shares now at $91.74, the stock is trading +1.0% above its intraday low and -1.5% below the session's peak.

Trading activity shows a volume of 20.36M, compared to an average daily volume of 14.16M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

BSX News

TipRanks 12h

Boston Scientific price target lowered to $124 from $136 at Barclays

Barclays lowered the firm’s price target on Boston Scientific (BSX) to $124 from $136 and keeps an Overweight rating on the shares. The firm updated the company...

TipRanks 2d

Underappreciated Champion-AF Catalyst Poised to Unlock Significant Upside for Boston Scientific’s Watchman Franchise

Boston Scientific, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Josh Jennings from TD Cowen maintained a Buy rating...

Simply Wall St 2d

A Look At Boston Scientific Valuation After Cooling Returns And Rich P/E Multiple

Advertisement How Boston Scientific stock looks after recent performance Boston Scientific (BSX) has drawn attention after its share price return over the pas...

Analyst ratings

95%

of 37 ratings

Buy

94.6%

Hold

5.4%

Sell

More BSX News

Simply Wall St 4d

Boston Scientific’s Nalu And Penumbra Bets Reframe Growth And Valuation Profile

Boston Scientific (NYSE:BSX) recently completed its acquisition of Nalu Medical, expanding its presence in pain management devices. The company has also announ...

Simply Wall St 5d

Does Boston Scientific Still Justify Its Premium After Recent Share Price Pullback

If you are wondering whether Boston Scientific's current share price reflects its true worth, you are not alone. This article is built to help you frame that qu...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.